Profile data is unavailable for this security.
About the company
Apollo Hospitals Enterprise Limited is an India-based integrated healthcare company. The Company is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. It is engaged in hospitals and hospitals-based services. Retail Health and Diagnostics segment includes clinics and diagnostics. Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,000 beds across 73 hospitals, 6000 pharmacies and 2500 clinics and diagnostic centers, as well as 500 telemedicine centers.
- Revenue in INR (TTM)204.69bn
- Net income in INR11.83bn
- Incorporated1979
- Employees82.79k
- LocationApollo Hospitals Enterprise Ltd"Ali Towers" Ill Floor, #55, Greams RoadCHENNAI 600006IndiaIND
- Phone+91 4 428290956
- Fax+91 4 428290956
- Websitehttps://www.apollohospitals.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aster DM Healthcare Ltd | 16.42bn | 2.51bn | 215.67bn | 14.02k | 89.02 | 6.28 | 55.37 | 13.13 | 4.86 | 108.08 | 32.21 | 68.98 | 0.1467 | 1.20 | 1.26 | 1,171,811.00 | 2.85 | 2.24 | 4.16 | 3.60 | 40.82 | 59.73 | 19.40 | 4.26 | 1.82 | 7.41 | 0.3501 | -- | 23.54 | -14.22 | 12.28 | -18.15 | 6.87 | -- |
| Krishna Institute Of Medical Sciencs Ltd | 27.05bn | 3.31bn | 226.96bn | 5.01k | 68.53 | 11.34 | 43.18 | 8.39 | 8.28 | 8.28 | 67.59 | 50.03 | 0.6765 | 10.76 | 8.26 | 5,396,635.00 | 9.10 | 13.71 | 11.33 | 16.73 | 79.37 | 54.29 | 13.45 | 15.53 | 0.8678 | 8.11 | 0.4384 | 0.00 | 13.67 | 22.17 | -7.78 | -- | 52.94 | -- |
| Dr. Lal PathLabs Ltd | 23.46bn | 4.01bn | 253.36bn | 4.10k | 63.15 | 12.66 | 46.13 | 10.80 | 48.17 | 48.17 | 281.60 | 240.30 | 0.9306 | 10.55 | 26.72 | 5,724,423.00 | 16.13 | 15.49 | 20.12 | 19.38 | 80.28 | 76.13 | 17.33 | 15.99 | 2.77 | 20.16 | 0.0889 | 23.86 | 10.40 | 13.10 | 49.78 | 12.43 | 6.44 | 31.95 |
| Narayana Hrudayalaya Ltd | 52.21bn | 7.79bn | 256.31bn | 11.66k | 32.91 | 8.05 | 24.79 | 4.91 | 38.35 | 38.35 | 257.10 | 156.86 | 0.9466 | 20.96 | 9.50 | 4,477,685.00 | 14.13 | 10.79 | 18.08 | 13.97 | 60.92 | 47.11 | 14.92 | 9.72 | 1.46 | 7.62 | 0.3468 | 9.64 | 10.91 | 11.89 | 30.19 | 67.89 | 45.27 | 31.95 |
| Fortis Healthcare Ltd | 73.13bn | 6.56bn | 496.61bn | 2.59k | 75.77 | 6.33 | 46.43 | 6.79 | 8.68 | 8.68 | 96.80 | 103.94 | 0.5544 | 14.45 | 9.84 | 28,202,260.00 | 5.34 | 3.54 | 7.68 | 4.57 | 76.46 | 73.04 | 9.63 | 7.63 | 0.4369 | 8.57 | 0.1197 | 8.90 | 9.45 | 9.05 | 1.72 | -- | 62.52 | -- |
| Apollo Hospitals Enterprise Limited | 204.69bn | 11.83bn | 961.47bn | 82.79k | 81.26 | 12.82 | 50.21 | 4.70 | 82.29 | 82.29 | 1,423.72 | 521.69 | 1.17 | 24.23 | 7.29 | 2,472,568.00 | 6.82 | 5.48 | 9.37 | 7.13 | 48.41 | 48.52 | 5.85 | 4.82 | 1.38 | 4.35 | 0.4822 | 21.94 | 14.73 | 14.66 | 9.71 | 30.65 | -- | 21.67 |
| Max Healthcare Institute Ltd | 60.08bn | 10.59bn | 969.99bn | 4.05k | 92.02 | 11.02 | 71.79 | 16.14 | 10.84 | 10.84 | 61.52 | 90.51 | 0.5053 | 15.02 | 12.53 | 14,846,260.00 | 8.91 | 6.98 | 10.05 | 8.06 | 79.38 | 76.77 | 17.63 | 15.02 | 1.20 | 14.69 | 0.1673 | 3.34 | 18.49 | 26.17 | -4.16 | -- | 46.69 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Life Insurance Corporation of India (Investment Portfolio)as of 30 Jun 2024 | 4.11m | 2.86% |
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Oct 2024 | 3.76m | 2.62% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 3.63m | 2.52% |
| Schroder Investment Management (Hong Kong) Ltd.as of 31 Jul 2024 | 3.04m | 2.11% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 2.63m | 1.83% |
| SBI Funds Management Ltd.as of 31 Oct 2024 | 2.10m | 1.46% |
| AllianceBernstein LPas of 30 Sep 2024 | 2.03m | 1.41% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 1.93m | 1.34% |
| Sands Capital Management LLCas of 31 Oct 2024 | 1.67m | 1.16% |
| Goldman Sachs Asset Management LPas of 14 Nov 2024 | 1.50m | 1.04% |
